The diagnostic utility of hypophosphatemia for differentiating generalized tonic-clonic seizures from syncope in dogs: A case control study. (January 2023)

• Record Type: Journal Article
• Authors: Kelmer, E.; Ohad, D.G.; Shamir, M.H.; Chai, O.; Lavie, S.; Sutton, G.A.; Aroch, I.; Klainbart, S.
• Is Part Of: Veterinary journal. Volume 291(2023)
• Publication Date: 2023-01
• Subjects: Creatine-kinase -- Epilepsy -- Status-epilepticus -- Phosphate -- Transient loss of consciousness; Veterinary medicine -- Periodicals; 636
• DOI: 10.1016/j.tvjl.2022.105914
• Languages: English
• ISSNs: 1090-0233

Abstract

Abstract: Transient hypophosphatemia is often detected in humans following generalized tonic-clonic seizures (GTCS), and serum phosphorus concentration (sPi) serves as a marker to differentiate GTCS from syncope. The objective of this retrospective study was to assess the usefulness of hypophosphatemia as a diagnostic marker for GTCS in dogs. Eighty-seven and 26 client-owned dogs with GTCS or syncope, respectively, were enrolled. Dogs were included if the episode occurred ≤ 3 h from presentation, and if sPi and serum creatinine (sCr) were measured. Dogs were excluded if aged < 1 year or if sCr exceeded 176.8 μmol/L. There were no group differences in sCr. Hypophosphatemia (sPi ≤ 0.97 mmol/L) occurred in 28 dogs (32%) in the seizure group, and in no dogs in the syncope group. Median sPi was significantly ( P < 0.001) lower in the seizure group (1 mmol/L, [range, 0.31–2.87 mmol/L]) compared to the syncope group (1.35 mmol/L [range, 0.97–2.71 mmol/L]). Furthermore, in dogs presented while seizing ( n = 24/87; 28%) median sPi was significantly lower compared to those that were not (0.9 mmol/L [range, 0.3–1.74 mmol/L] vs. 1 mmol/L [range, 0.33–2.18 mmol/L], P = 0.050). ROC analysis of sPi as a marker of GTCS yielded an AUC of 0.757 (95% confidence interval 0.667–0.847), with an optimum cutoff point of 0.97 mmol/L, corresponding to specificity and sensitivity levels of 100% and 44%, respectively. In conclusion, sPi may, in certain cases, serve as an additional diagnostic tool to differentiate GTCS from syncope in dogs. Hypophosphatemia, especially with sPi < 0.97 mmol/L, may be useful in clinical practice to rule in GTCS. Highlights: Differentiating seizures from syncope may be challenging in some dogs. Serum phosphate (sPi) may serve as an additional biomarker for seizures in dogs. Median sPi was significantly lower in dogs presented for seizures compared to syncope. Dogs presented while seizing had a lower sPi compared to dogs who were not. Hypophosphatemia, especially sPi < 0.97 mmol/L may be useful to rule-in seizures.